Association between cytotoxic and invasive pseudomonas aeruginosa and clinical outcomes in bacterial keratitis

JAMA Ophthalmology

Volumn 131, Issue 2, 2013, Pages 147-153

  Borkar, Durga S ^a   Fleiszig, Suzanne M J ^b,c   Leong, Chelsia ^b   Lalitha, Prajna ^d   Srinivasan, Muthiah ^d   Ghanekar, Avanti A ^b   Tam, Connie ^b   Li, Wing Y ^b   Zegans, Michael E ^e   McLeod, Stephen D ^a   Lietman, Thomas M ^a   Acharya, Nisha R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ARAVIND EYE CARE SYSTEM   (India)

^e DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN; MOXIFLOXACIN; PLACEBO; PREDNISOLONE SODIUM PHOSPHATE;

ADJUVANT THERAPY; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL KERATITIS; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; CORNEA ULCER; CORTICOSTEROID THERAPY; CYTOTOXICITY; DISEASE SEVERITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RANDOMIZED CONTROLLED TRIAL; STRAIN DIFFERENCE; VISUAL ACUITY;

ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; BACTERIAL TOXINS; BACTERIAL TYPING TECHNIQUES; CORNEAL ULCER; DNA, BACTERIAL; EXOTOXINS; EYE INFECTIONS, BACTERIAL; GENOTYPE; GLUCOCORTICOIDS; HUMANS; L-LACTATE DEHYDROGENASE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; QUINOLINES; VIRULENCE; VISUAL ACUITY;

EID: 84874056734     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2013.778     Document Type: Article

References (35)

1. Schein OD, Ormerod LD, Barraquer E, et al. Microbiology of contact lensrelated keratitis. Cornea. 1989;8(4):281-285.
2. Liesegang TJ, Forster RK. Spectrum of microbial keratitis in south Florida. Am J Ophthalmol. 1980;90(1):38-47.
3. Koidou-Tsiligianni A, Alfonso E, Forster RK. Ulcerative keratitis associated with contact lens wear. Am J Ophthalmol. 1989;108(1):64-67.
4. Gudmundsson OG, Ormerod LD, Kenyon KR, et al. Factors influencing predilection and outcome in bacterial keratitis. Cornea. 1989;8(2):115-121.
5. Asbell P, Stenson S. Ulcerative keratitis: survey of 30 years' laboratory experience. Arch Ophthalmol. 1982;100(1):77-80.
6. Ormerod LD, Hertzmark E, Gomez DS, Stabiner RG, Schanzlin DJ, Smith RE. Epidemiology of microbial keratitis in Southern California: a multivariate analysis. Ophthalmology. 1987;94(10):1322-1333.
7. Varaprasathan G, Miller K, Lietman T, et al. Trends in the etiology of infectious corneal ulcers at the F. I. Proctor Foundation. Cornea. 2004;23(4):360-364.
8. Fleiszig SM, Lee EJ, Wu C, et al. Cytotoxic strains of Pseudomonas aeruginosa can damage the intact corneal surface in vitro. CLAO J. 1998;24(1):41-47.
9. Fleiszig SMJ, Zaidi TS, Preston MJ, Grout M, Evans DJ, Pier GB. Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa. Infect Immun. 1996;64(6):2288-2294.
10. Lee EJ, Cowell BA, Evans DJ, Fleiszig SMJ. Contribution of ExsA-regulated factors to corneal infection by cytotoxic and invasive Pseudomonas aeruginosa in a murine scarification model. Invest Ophthalmol Vis Sci. 2003;44(9):3892- 3898.
11. Winstanley C, Kaye SB, Neal TJ, Chilton HJ, Miksch S, Hart CA; Microbiology Ophthalmic Group. Genotypic and phenotypic characteristics of Pseudomonas aeruginosa isolates associated with ulcerative keratitis. J Med Microbiol. 2005; 54(pt 6):519-526.
12. Fleiszig SM, Wiener-Kronish JP, Miyazaki H, et al. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect Immun. 1997;65(2):579-586.
13. Fleiszig SM, Zaidi TS, Fletcher EL, Preston MJ, Pier GB. Pseudomonas aeruginosa invades corneal epithelial cells during experimental infection. Infect Immun. 1994;62(8):3485-3493.
14. Fleiszig SM, Zaidi TS, Pier GB. Pseudomonas aeruginosa invasion of and multiplication within corneal epithelial cells in vitro. Infect Immun. 1995;63(10): 4072-4077.
15. Angus AA, Lee AA, Augustin DK, Lee EJ, Evans DJ, Fleiszig SM. Pseudomonas aeruginosa induces membrane blebs in epithelial cells, which are utilized as a niche for intracellular replication and motility. Infect Immun. 2008;76(5):1992-2001.
16. Finck-Barbançon V, Goranson J, Zhu L, et al. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol. 1997;25(3):547-557.
17. Hauser AR. The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol. 2009;7(9):654-665.
18. Lee EJ, Truong TN, Mendoza MN, Fleiszig SM. A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics. Curr Eye Res. 2003;27(5):289-299.
19. Cole N, Willcox MD, Fleiszig SM, et al. Different strains of Pseudomonas aeruginosa isolated from ocular infections or inflammation display distinct corneal pathologies in an animal model. Curr Eye Res. 1998;17(7):730-735.
20. Cowell BA, Weissman BA, Yeung KK, et al. Phenotype of Pseudomonas aeruginosa isolates causing corneal infection between 1997 and 2000. Cornea. 2003; 22(2):131-134.
21. Zhu H, Conibear TC, Bandara R, Aliwarga Y, Stapleton F, Willcox MD. Type III secretion system-associated toxins, proteases, serotypes, and antibiotic resistance of Pseudomonas aeruginosa isolates associated with keratitis. Curr Eye Res. 2006;31(4):297-306.
22. Lomholt JA, Poulsen K, Kilian M. Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors. Infect Immun. 2001;69(10):6284-6295.
23. Choy MH, Stapleton F, Willcox MD, Zhu H. Comparison of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens- and non-contact lens-related keratitis. J Med Microbiol. 2008;57(pt 12):1539-1546.
24. Ledbetter EC, Mun JJ, Kowbel D, Fleiszig SM. Pathogenic phenotype and genotype of Pseudomonas aeruginosa isolates from spontaneous canine ocular infections. Invest Ophthalmol Vis Sci. 2009;50(2):729-736.
25. Srinivasan M, Mascarenhas J, Rajaraman R, et al; Steroids for Corneal Ulcers Trial Group. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol. 2012;130(2):143-150.
26. Srinivasan M, Mascarenhas J, Rajaraman R, et al; Steroids for Corneal Ulcers Trial Group. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Arch Ophthalmol. 2012;130(2):151-157.
27. Fleiszig SM, Kwong MS, Evans DJ. Modification of Pseudomonas aeruginosa interactions with corneal epithelial cells by human tear fluid. Infect Immun. 2003; 71(7):3866-3874.
28. Sy A, Srinivasan M, Mascarenhas J, et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Invest Ophthalmol Vis Sci. 2012;53(1):267-272.
29. Zolfaghar I, Evans DJ, Ronaghi R, Fleiszig SM. Type III secretion-dependent modulation of innate immunity as one of multiple factors regulated by Pseudomonas aeruginosa RetS. Infect Immun. 2006;74(7):3880-3889.
30. Mun JJ, Tam C, Kowbel D, et al. Clearance of Pseudomonas aeruginosa from a healthy ocular surface involves surfactant protein D and is compromised by bacterial elastase in a murine null-infection model. Infect Immun. 2009;77(6): 2392-2398.
31. Sin DD, Man SF, Marciniuk DD, et al; ABC (Advair, Biomarkers in COPD) Investigators. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177(11):1207-1214.
32. Ni M, Evans DJ, Hawgood S, Anders EM, Sack RA, Fleiszig SM. Surfactant protein D is present in human tear fluid and the cornea and inhibits epithelial cell invasion by Pseudomonas aeruginosa. Infect Immun. 2005;73(4):2147-2156.
33. Ni M, Tam C, Verma A, et al. Expression of surfactant protein D in human corneal epithelial cells is upregulated by Pseudomonas aeruginosa. FEMS Immunol Med Microbiol. 2008;54(2):177-184.
34. McCormick CC, Hobden JA, Balzli CL, et al. Surfactant protein D in Pseudomonas aeruginosa keratitis. Ocul Immunol Inflamm. 2007;15(5):371-379.
35. Bradbury RS, Roddam LF, Merritt A, Reid DW, Champion AC. Virulence gene distribution in clinical, nosocomial and environmental isolates of Pseudomonas aeruginosa. J Med Microbiol. 2010;59(pt 8):881-890.